PAVmed Inc.
PAVM· Nasdaq
Released Aug 12, 2021, after the close
10-Q filed Aug 16, 2021, 47 days after period end · 0001493152-21-020273
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$11.47M | -$5.58M | -$3.59M | -$5.07M |
| EPS Diluted | -$0.14 | -$0.12 | -$0.13 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR